These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 65221)

  • 41. Treatment of 49 unrandomized patients with advanced Hodgkin's disease.
    Chisesi T; Ricciardi O; Dal Fior S; Cappellari F; Pozza F; Battista R; Cortelazzo S; Capnist G; D'Emilio A; Rodeghiero F
    Tumori; 1983 Oct; 69(5):463-7. PubMed ID: 6196890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
    Bloomfield CD; Weiss RB; Fortuny I; Vosika G; Kennedy BJ
    Cancer; 1976 Jul; 38(1):42-8. PubMed ID: 947533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
    Straus DJ; Myers J; Passe S; Young CW; Nisce LZ; Lee BJ; Koziner B; Arlin Z; Kempin S; Gee T; Clarkson BD
    Cancer; 1980 Jul; 46(2):233-40. PubMed ID: 6155987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cytostatic chemotherapy of lymphogranulomatosis].
    Dold U
    Dtsch Med Wochenschr; 1978 Feb; 103(6):235-8. PubMed ID: 75085
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
    Porzig KJ; Portlock CS; Robertson A; Rosenberg SA
    Cancer; 1978 May; 41(5):1670-5. PubMed ID: 77180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination chemotherapy of advanced Hodgkin's disease. A review.
    Goldsmith MA; Carter SK
    Cancer; 1974 Jan; 33(1):1-8. PubMed ID: 4129559
    [No Abstract]   [Full Text] [Related]  

  • 47. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
    Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
    Diggs CH; Wiernik PH; Levi JA; Kvols LK
    Cancer; 1977 May; 39(5):1949-54. PubMed ID: 870162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination chemotherapy for stage IV Hodgkin's disease (Report no 14).
    Goldman JM
    Clin Radiol; 1981 Sep; 32(5):531-6. PubMed ID: 6168426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
    Ferrant A; Hamoir V; Binon J; Michaux JL; Sokal G
    Cancer; 1985 Jan; 55(2):317-22. PubMed ID: 2578082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
    Kurnick JE; White M; Ware DE; Robinson WA
    Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal treatment of early-stage Hodgkin disease.
    Sullivan JW; Cooper JS
    Radiology; 1993 Feb; 186(2):312-3. PubMed ID: 7678466
    [No Abstract]   [Full Text] [Related]  

  • 53. A new combination chemotherapy for resistant Hodgkin disease.
    Vinciguerra V; Coleman M; Jarowski CI; Degnan TJ; Silver RT
    JAMA; 1977 Jan; 237(1):33-5. PubMed ID: 62854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination chemotherapy of Hodgkin's disease in children.
    Kolygin BA
    Cancer; 1976 Oct; 38(4):1494-7. PubMed ID: 991072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma.
    Corder MP; Clamon GH; Wiesenfeld M
    Cancer Invest; 1984; 2(3):193-8. PubMed ID: 6203626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hodgkin's disease (HD): a historical perspective.
    Tura S; Mazza P; Zinzani PL; Verlicchi F; Baccarani M; Lauria F; Fiacchini M; Gobbi M; Bandini G; Emiliani E
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1315-23. PubMed ID: 2435555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination chemotherapy including bleomycin in the treatment of advanced Hodgkin's disease.
    Bezwoda WR; MacDonald DF; Gear JS; Derman DP; Bothwell TH; Sqi S; Hurwitz S; Lewis D
    S Afr Med J; 1978 Mar; 53(10):369-73. PubMed ID: 77560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prednisone in MOPP chemotherapy for Hodgkin's disease.
    Jacobs C; Portlock CS; Rosenberg SA
    Br Med J; 1976 Dec; 2(6050):1469-71. PubMed ID: 1000259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
    Br Med J; 1975 Aug; 3(5980):413-4. PubMed ID: 1098721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Criteria for choice of therapeutic procedures in lymphomas].
    Vettore L; Pizzolo G
    Minerva Med; 1975 Apr; 66(31):1456-62. PubMed ID: 48217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.